Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Invivo Therapeutics Holdings Corp (NVIV)

Invivo Therapeutics Holdings Corp (NVIV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
InVivo Therapeutics Announces Reverse Stock Split

InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced a 1-for-30 reverse stock split of its common stock and a proportionate reduction in its authorized common stock. The company anticipates...

NVIV : 7.12 (-0.56%)
After Yesterday's Decline of 7.07%, Invivo Therapeut Offers Investors Better Value

Invivo Therapeut (NASDAQ:NVIV) traded in a range yesterday that spanned from a low of $0.26 to a high of $0.29. Yesterday, the shares fell 7.1%, which took the trading range below the 3-day low of $0.27...

NVIV : 7.12 (-0.56%)
Invivo Therapeut Rises 7.16% on Heavy Volume: Watch For Potential Pullback

Invivo Therapeut (NASDAQ:NVIV) traded in a range yesterday that spanned from a low of $0.16 to a high of $0.19. Yesterday, the shares gained 7.2%, which took the trading range above the 3-day high of...

NVIV : 7.12 (-0.56%)
InVivo Therapeutics Announces Closing of Public Offering of Common Stock

InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) today announced the closing of its previously announced public offering of 7,000,000 shares of its common stock, par value $0.00001 per share, at a price...

NVIV : 7.12 (-0.56%)
Watch for Invivo Therapeut to Potentially Rebound After Falling 34.51% Yesterday

Invivo Therapeut (NASDAQ:NVIV) traded in a range yesterday that spanned from a low of $0.13 to a high of $0.17. Yesterday, the shares fell 34.5%, which took the trading range below the 3-day low of $0.22...

NVIV : 7.12 (-0.56%)
InVivo Therapeutics Announces Pricing of Public Offering of Common Stock

InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) today announced the pricing of a public offering of 7,000,000 shares of its common stock, par value $0.00001 per share, at a price to the public of $0.12...

NVIV : 7.12 (-0.56%)
InVivo Therapeutics Announces Proposed Public Offering of Common Stock

InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) today announced that it has commenced a proposed public offering of shares of its common stock, par value $0.00001 per share. The proposed public offering...

NVIV : 7.12 (-0.56%)
InVivo Therapeutics Announces Appointment of Robert Rosenthal to Board of Directors

InVivo Therapeutics Holdings Corp. (NVIV) today announced the appointment of Robert J. Rosenthal, Ph.D., to the Company's Board of Directors, effective November 8, 2019. Dr. Rosenthal brings more than...

NVIV : 7.12 (-0.56%)
InVivo Therapeutics Provides Enrollment Update for INSPIRE 2.0 Study for the Treatment of Acute Spinal Cord Injury

InVivo Therapeutics Holdings Corp. (NVIV) today announced that a total of five patients have been enrolled into The INSPIRE 2.0 Study (InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold(TM)...

NVIV : 7.12 (-0.56%)
InVivo Therapeutics Announces Publication of CONTEMPO Registry Study Data in Peer-Reviewed Journal Spinal Cord

InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced the publication of a manuscript in the peer-reviewed journal Spinal Cord describing its CONTEMPO registry study data. The CONTEMPO registry...

NVIV : 7.12 (-0.56%)
InVivo Therapeutics Announces Postponement of Annual Meeting

InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced that it has postponed its 2019 annual meeting of stockholders. The annual meeting, which was originally scheduled for June 11, 2019, had...

NVIV : 7.12 (-0.56%)
InVivo Therapeutics Announces Enrollment of First Two Patients into the INSPIRE 2.0 Study for the Treatment of Acute Spinal Cord Injury

InVivo Therapeutics Holdings Corp. (NVIV) today announced that the first two patients have been enrolled into The INSPIRE 2.0 Study (InVivo Study of Probable Benefit of the Neuro-Spinal ...

NVIV : 7.12 (-0.56%)
Research Report Identifies 1-800 FLOWERS.COM, Ceragon Networks, Tremont Mortgage Trust, Golden Minerals, GEE Group, and InVivo Therapeutics with Renewed Outlook -- Fundamental Analysis, Calculating Forward Movement

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of 1-800 FLOWERS.COM, Inc....

FLWS : 16.59 (+0.18%)
CRNT : 1.92 (+1.05%)
TRMT : 5.95 (+0.17%)
AUMN : 0.26 (unch)
JOB : 0.41 (unch)
NVIV : 7.12 (-0.56%)
InVivo Therapeutics Announces Presentation of Twelve-Month Results from the INSPIRE Study of the Investigational Neuro-Spinal Scaffold(TM) in Acute Thoracic Complete Spinal Cord Injury

InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) ("InVivo" or the "Company") today announced the presentation of the twelve-month results from the company's single-arm INSPIRE study (InVivo...

NVIV : 7.12 (-0.56%)
InVivo Therapeutics Reports 2018 Year-end Financial Results and Provides Business Update

InVivo Therapeutics Holdings Corp. (NVIV) today reported financial results for the year ended December 31, 2018.

NVIV : 7.12 (-0.56%)
InVivo Therapeutics Announces Appointment of Richard Christopher as Chief Financial Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

InVivo Therapeutics Holdings Corp. (Nasdaq:NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries (SCIs), today announces...

ICAD : 11.98 (+1.87%)
NVIV : 7.12 (-0.56%)

Van Meerten Stock Picks

My 5 Favorite Mid Caps
Summary 100% technical buy signals with current momentum.
CRUS +0.89 , SEDG +0.05 , THC -0.57 , TER -2.42 , LITE -3.44
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar